Literature DB >> 7634881

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.

N A Dewan1, S D Reeb, N C Gupta, L S Gobar, W J Scott.   

Abstract

BACKGROUND AND
OBJECTIVE: Positron emission tomography (PET) utilizing 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) has been demonstrated to be highly accurate in differentiating benign from malignant pulmonary nodules. Transthoracic fine-needle aspiration biopsy (TTNA) is generally the initial procedure of choice in the evaluation of peripheral lesions suspected to be malignant. Our objective was to determine whether PET-FDG imaging, a noninvasive test, was equally efficacious as TTNA in the evaluation of lung lesions suspected to be malignant. PATIENT SELECTION: Thirty-three patients with 35 lung lesions who had undergone both PET-FDG imaging and TTNA were retrospectively selected from an ongoing prospective study of PET-FDG imaging in the evaluation of solitary pulmonary nodules. MEASUREMENTS: Diagnostic efficacy was determined by calculating sensitivity, specificity, positive and negative predictive value, and overall predictive accuracy for both PET-FDG imaging and TTNA in differentiating benign from malignant lesions. Complication rate also was documented for the two tests.
RESULTS: The PET imaging correctly identified all 26 malignant lesions, including 21 lesions diagnosed by TTNA and 7 of the 9 benign lung lesions. The TTNA was positive for malignancy in 21 lung lesions and missed the diagnosis of malignancy in 5 lesions. Diagnostic sensitivity, specificity, positive and negative predictive value, and overall predictive accuracy was 100, 78, 93, 100, and 94% for PET imaging and 81, 100, 100, 64, and 86 for TTNA, respectively. Pneumothorax was documented in 16 patients (46%), and 9 patients (26%) required a chest tube. There were no complications with PET imaging.
CONCLUSION: We conclude that PET imaging of the lung is as efficacious as TTNA, with less risk, and offers an alternate noninvasive option in the evaluation and management of lung lesions suspected to be malignant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634881     DOI: 10.1378/chest.108.2.441

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests.

Authors:  Paul Cronin; Ben A Dwamena; Aine Marie Kelly; Steven J Bernstein; Ruth C Carlos
Journal:  Eur Radiol       Date:  2008-07-08       Impact factor: 5.315

Review 2.  18F-fluorodeoxyglucose PET scans in lung cancer.

Authors:  J M Hughes
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

4.  Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

Authors:  A Guhlmann; M Storck; J Kotzerke; F Moog; L Sunder-Plassmann; S N Reske
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

Review 5.  Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.

Authors:  Poul Henning Madsen; Paw Christian Holdgaard; Janne Buck Christensen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-11       Impact factor: 9.236

6.  The role of 18F-FDG PET/CT in pediatric lymph-node acute lymphoblastic leukemia involvement.

Authors:  Angelina Cistaro; Francesco Saglio; Sebastian Asaftei; Piercarlo Fania; Massimo Berger; Franca Fagioli
Journal:  Radiol Case Rep       Date:  2015-11-06

7.  Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis.

Authors:  Y Lacasse; E Wong; G H Guyatt; D J Cook
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 8.  Current role of positron emission tomography in thoracic oncology.

Authors:  V J Lowe; K S Naunheim
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 9.  [(18)F]-FDG PET and localized fibrous mesothelioma.

Authors:  J Cortes; J Rodriguez; M J Garcia-Velloso; N Rodriguez-Espiteri; J F Boan; J M Castellano; W Torre
Journal:  Lung       Date:  2003       Impact factor: 2.584

10.  Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Authors:  Irawati Lemonnier; Cédric Baumann; Nicolas Jay; Kazem Alzahouri; Patrick Arveux; Damien Jolly; Catherine Lejeune; Michel Velten; Fabien Vitry; Marie-Christine Woronoff-Lemsi; Francis Guillemin
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.